Identifying Genomic and Microbial Contributions in Early Childhood-Inflammatory Bowel Disease
Identifying Genomic and Microbial Contributions in Early Childhood-Inflammatory Bowel Disease
批准号:
10629411
负责人:
Maire Abraham Conrad
金额:
$18.53万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-08-16 至 2025-05-31
关键词:
2 year old6 year oldAchievementAdultAgeChildChildhoodChronic DiseaseCollaborationsComplexCoupledCross-Sectional StudiesDataDefectDevelopmentDevelopment PlansDiagnosisDiseaseDisease susceptibilityEnrollmentEnvironmentEnvironmental ExposureEnvironmental Risk FactorEtiologyFrequenciesFutureGenesGeneticGenomicsImmuneImmune responseImmune systemImmunologicsIncidenceInflammationInflammatory Bowel DiseasesIntestinesLeadLifeMentorsMorbidity - disease rateNewly DiagnosedOligogenic TraitsOnset of illnessPathogenesisPathogenicityPathway interactionsPatientsPhenotypePopulationPredispositionPrevalenceProcessQuality of lifeRefractoryResearchResearch PersonnelResearch ProposalsRoleSNP arraySeverity of illnessShotgunsStructureSusceptibility GeneTechnologyTimeTrainingTreatment outcomeUnderserved PopulationVariantWorkage groupbiomarker identificationcareercareer developmentconventional therapydisease diagnosisdisease phenotypedisorder riskearly childhoodearly life exposureearly onsetexome sequencinggut microbiomegut microbiotaillness lengthimprovedinfancyinnovationinsightlarge datasetsmetagenomic sequencingmicrobialmicrobial communitymicrobial signaturemicrobiomemicrobiotamolecular sequence databasemultidisciplinarynovelpolygenic risk scorerare variantresearch and developmentresponseskill acquisitionskillsstool samplesymposiumtargeted treatmenttherapeutic targettherapeutically effectivetherapy designtranslational study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Inflammatory bowel disease diagnosed before age 6 years can be distinguished from older onset pediatric and
adult IBD by its unique phenotype of severe morbidity, poor response to conventional therapies, greater duration
of disease, and its rapidly increasing prevalence. This population is further divided into those diagnosed <2 year
of age, infantile IBD, and children diagnosed between 2 and 6 years old, whom we refer to as early childhood
IBD for this proposal. While pediatric IBD is a complex polygenic disease, we and others have identified causative
monogenic defects in infantile IBD. However, little is understood about the pathogenic mechanisms in early
childhood IBD. The underlying hypothesis of this proposal is that patients with early childhood IBD have a unique
host genomic background coupled with early life exposures. This interaction leads to a dysfunctional dynamic
between the immune response and the intestinal microbial community structure. The PI will utilize this career
development and research plan in order to gain skills and establish collaborations which will allow her to develop
future translational studies leveraging large data sets to identify future therapeutic targets to improve treatment
outcomes for early childhood-IBD.
Using cutting edge technology, we will generate genomic and microbiome data to study children with early
childhood IBD. In Aim 1, the PI will identify the role of both rare and low frequency variants using whole exome
sequencing and calculate the polygenic risk score based on known IBD susceptibility loci in order to characterize
the genetic burden of the early childhood IBD phenotype. In Aim 2, stool samples will be collected during the
first 8 weeks of initiating IBD treatment in 100 newly diagnosed early childhood IBD patients in addition to
collecting data regarding environmental exposures. Shotgun metagenomic sequencing will be used to discern
the microbial community structure at each time point. The baseline microbiota will be correlated with early life
environmental exposures and the longitudinal microbiota will be analyzed in the context of changing disease
activity. As part of her career development plan, this research plan with allow the PI to refine and acquire skills
with the support of her mentors, receive hands on training from her collaborators, enroll in formal coursework,
and participate in multidisciplinary seminars and conferences to prepare her for a future career as an
independent investigator.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s11894-020-00773-3
发表时间:
2020-06-15
期刊:
Current gastroenterology reports
影响因子:
--
作者:
[Conrad MA, Kelsen JR]
通讯作者:
Kelsen JR
DOI:
10.1111/pde.14544
发表时间:
2021-05
期刊:
PEDIATRIC DERMATOLOGY
影响因子:
1.5
作者:
[Havele, Sonia A., Clark, Ashley K., Oboite, Michelle, Conrad, Maire A., Perman, Marissa J., Rubin, Adam I., Treat, James R.]
通讯作者:
Treat, James R.
Pediatric Global Health in Children with Very Early-Onset Inflammatory Bowel Disease.
患有极早发炎症性肠病的儿童的儿科全球健康。
DOI:
10.1093/jpepsy/jsab035
发表时间:
2021
期刊:
Journal of pediatric psychology
影响因子:
3.6
作者:
[Holbein,ChristinaE, Plevinsky,Jill, Patel,Trusha, Conrad,MaireC, Kelsen,JudithR]
通讯作者:
Kelsen,JudithR
Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease: A Clinician's Dilemma.
小儿炎症性肠病中的艰难梭菌感染:临床医生的困境。
DOI:
10.1093/jpids/piab069
发表时间:
2021
期刊:
Journal of the Pediatric Infectious Diseases Society
影响因子:
3.2
作者:
[Conrad,MáireA, Kelsen,JudithR]
通讯作者:
Kelsen,JudithR
Editorial to Temporal Gut Microbial Changes Predict Recurrent Clostridium difficile Infection in Patients With and Without Ulcerative Colitis.
颞部肠道微生物变化预测患有和不患有溃疡性结肠炎的患者复发艰难梭菌感染的社论。
DOI:
10.1093/ibd/izz336
发表时间:
2020
期刊:
Inflammatory bowel diseases
影响因子:
4.9
作者:
[Conrad,MaireA, Kelsen,JudithR]
通讯作者:
Kelsen,JudithR
Identifying Genomic and Microbial Contributions in Early Childhood-Inflammatory Bowel Disease
-
批准号:10162582
-
项目类别:
-
资助金额:$18.53万
-
财政年份:2019
-
负责人:Maire Abraham Conrad
-
依托单位:
Identifying Genomic and Microbial Contributions in Early Childhood-Inflammatory Bowel Disease
-
批准号:10408105
-
项目类别:
-
资助金额:$18.53万
-
财政年份:2019
-
负责人:Maire Abraham Conrad
-
依托单位:
海外基金